Sleep 1996; 19(9 Suppl): S90–100. MEDLINE e14. Seifert V. Wann ist der Chirurg gefragt? Therapie der Adipositas. Der Allgemeinarzt 2006; 28: 6–8.
Gubra releases its results for the first quarter of 2024. For the CRO business, performance was strong with organic revenue growth of 51% year-over-year. Within the D&P business, there was significant ...
Gubra announces an upgrade to its full-year 2024 financial outlook. Organic revenue growth for the CRO business is now expected to be 15-20% (previously 10-15%) and adjusted EBIT-margin is expected ...